Home arrow Finance arrow fnews arrow Biocon is world's 7th largest biotech employer: Report Tuesday, 02 December 2008
 
 
   
Google
 
 
HomeWorldFinanceSci/TechHealthEntertainmentSportsContact Us

Biocon is world's 7th largest biotech employer: Report Print E-mail
Tag it:
Delicious
Furl it!
Spurl
NewsVine
Reddit
YahooMyWeb
Technorati
Wists
YahooMyWeb
Blinkbits
BlinkList
blogmarks
co.mments
connotea
Digg
Stumble
User Rating: / 0
PoorBest 
Written by ANI   
Monday, 22 September 2008

Bangalore, Sept 22 (ANI/Business Wire India): Biocon, India's pioneering biotechnology enterprise, announced today that the company has been ranked as the 7th largest employer amongst the top global biotechnology companies, according to a report released by Med Ad News.

The report takes into consideration drug based firms, as these companies provide the best numbers to track the progress of the sector. Companies have been ranked by number of employees and Biocon Limited is the only Asian company to feature at Number 7.

BIO 2008, held in San Diego recently, stated that the global biotechnology industry will be a $100 billion annual business by 2010. The actual revenue has reached 85 billion dollars in 2007.

There are close to 5000 biotech companies across the globe. The top 25 biotech companies represent 62 percent of all biotech sales and probably over 90 percent of income.

Reacting to the listing, Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon Limited said, "It is a matter of immense pride for Biocon to be ranked amongst the top global league of Biotech companies. This is a validation of our consistent effort at attaining global leadership and also highlights the true potential of this sector in a country like India. This industry will be a key driver in India's progress towards economic development."

Biocon Limited is India's pioneer biotechnology enterprise established in 1978. Biocon and its two subsidiaries, Syngene and Clinigene form a fully integrated biotechnology enterprise, with specialized focus on biopharmaceuticals, contract research and clinical research. Strategic international acquisitions, such as acquiring a majority in the German pharmaceutical company, AxiCorp, have given Biocon wider global access and greater market penetration. Many of our products have USFDA and EMEA acceptance. (ANI)


Add as favourites (14)

Be first to comment this article
RSS comments

Write Comment
  • Please keep the topic of messages relevant to the subject of the article.
  • Personal verbal attacks will be deleted.
  • Please don't use comments to plug your web site. Such material will be removed.
  • Just ensure to *Refresh* your browser for a new security code to be displayed prior to clicking on the 'Send' button.
  • Keep in mind that the above process only applies if you simply entered the wrong security code.
Name:
E-mail
BBCode:Web AddressEmail AddressBold TextItalic TextUnderlined TextQuoteCodeOpen ListList ItemClose List
Comment:



Code:* Code
I wish to be contacted by email regarding additional comments

Powered by AkoComment Tweaked Special Edition v.1.4.4

Last Updated ( Monday, 22 September 2008 )
 
< Prev   Next >

Experimental Schizophrenia Dru...
Guest poster wrote: \"pay no attention to the angry pfizer ...
More...

Intimacy Linked to Lower Stres...
What we should do?
More...

Intimacy Linked to Lower Stres...
New Study! What is new about it? All couples will tell you t...
More...

Freddie Mac did pay millions t...
The third and last U.S. Presidential Debate took place in He...
More...

Nutritionist Reveals 20 Functi...
very ggod.
More...

 
About Us | Privacy Policy | Advertise | Contact Us
©2007-2008 NewsLocale.org, All Rights Reserved